Gianluca Roma

Company: EV Therapeutics

Job title: Chief Executive Officer

Bio:

Gianluca Roma is the CEO and co-founder of EV Therapeutics, a pre-clinical company developing extracellular vesicle-based therapeutic cancer vaccines to help patients qualify for checkpoint inhibitor therapy in gastrointestinal cancers. Gianluca began his career at Gen-Probe where he developed several FDA-approved clinical diagnostic tests. Upon completing an MBA, he transitioned into product management and worked at several large biotechnology companies. He went on to co-found InKaryo Corporation, a next-generation sequencing start-up and led the business to its acquisition by Esperite. Later, Roma joined Applied StemCell and led their newly-formed AccuRef Diagnostics business to acquisition by Abcam.

Seminars:

Novel Exosome-Based Therapies for Treating Colorectal Cancer 2:10 pm

T cells costimulatory functions are affected by tumor-intrinsic mechanism in colorectal cancer leading to host immune suppression  Modified colorectal cancer tumor EVs without immune suppressive microRNAs can stimulate antitumor immunity and has therapeutic potential in advanced disease models  Harnessing the immunogenicity of modified tumor EVs can be developed as a novel therapeutic strategy to reduce cancer…Read more

day: Conference Day Two